Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Vanadium Compounds”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 739 records · Page 41Linked to original sources
PubMed2001

Modeling the electronic behavior of gamma-LiV2O5: a microscopic study.

We determine the electronic structure of the one-dimensional spin- 1 / 2 Heisenberg compound gamma-LiV2O5, which has two inequivalent vanadium ions, V(1) and V(2), via density-functional calculations. We find a relative V(1)-V(2) charge ordering of roughly 70:30. We discuss the influence of the charge ordering on the electronic structure and the magnetic behavior. We give estimates of the basic hopping matrix elements and compare with the most studied (alpha)'-NaV2O5.

Journal Article↗
PubMed1998

X-ray absorption fine structure of V(2)O(5) and Li(x)V(2)O(5).

Vanadium K-edge XAFS measurements of five compounds were carried out. The compounds studied were crystalline V(2)O(5) and four types of Li(x)V(2)O(5) with different insertion levels x, which show different EMFs (2.0-3.4 V). The EXAFS data analysis shows no remarkable difference in the V-O distances in the five compounds, showing that the structure of the VO(5) square pyramids changes only slightly as lithium atoms are intercalated into the V(2)O(5). In the XANES spectra, three peaks are observed for crystalline V(2)O(5) and Li(x)V(2)O(5) (3.4 V). When the EMF is decreased, the intensity difference between the first and second peaks disappears and the third peak shifts to lower energy. The XANES data were analysed using full multiple-scattering calculations. In the calculated spectra the intensity of the first peak increases as the V(2)O(5) intercalates lithium atoms.

Journal Article↗
PubMed2000

[Vanadium and diabetes: pancreatic and peripheral insulinomimetic properties] [In Process Citation]

A very large body of research has been devoted to diabetes mellitus with the goal of better understanding this complex disease for better patient treatment. Pathophysiological research in the rat has focused on Pharmacological research suggests that vanadium could be a possible therapeutic agent due to its activity on insulin secretion and its peripheral insulinomimetic properties. Results suggest that the antidiabetic properties of vanadium result from Vanadium derivatives thus comprise a novel class of compounds with promising therapeutic potential and favorable pharmacokinetic properties (oral administration).

Journal Article↗
PubMed1985

Interaction of inorganic vanadate with glucose-6-phosphate dehydrogenase. Nonenzymic formation of glucose 6-vanadate.

Inorganic vanadate (Vi) activates catalysis by glucose-6-phosphate dehydrogenase of the oxidation of glucose by NADP+. As the concentration of Glu-6-P dehydrogenase is increased, the rate of the vanadate-activated glucose oxidation becomes less sensitive to increases in enzyme concentration. The rate of glucose oxidation in the absence of Vi increases linearly with Glu-6-P dehydrogenase concentration. These results are interpreted in terms of nonenzymic formation of glucose 6-vanadate. At high enzyme concentration, vanadate ester formation becomes partially rate-limiting, and extrapolation to infinite Glu-6-P dehydrogenase concentration allows determination of the second order rate constant for formation of the ester. In separate experiments designed to test the proposed mechanism, it was found that Vi, at concentrations at which it strongly activates catalysis by Glu-6-P dehydrogenase of glucose oxidation, has no effect on the rates of oxidation of glucose 6-phosphate or 6-deoxyglucose catalyzed by Glu-6-P dehydrogenase. Sulfate, which is known to activate glucose oxidation and to inhibit glucose 6-phosphate oxidation, strongly activates 6-deoxyglucose oxidation. These experiments show that the 6-hydroxyl group of glucose is essential for the observed activation by Vi and are also consistent with the formation of glucose 6-vanadate. Also, the rate of the sulfate-activated glucose oxidation increases linearly with Glu-6-P dehydrogenase concentration. These results are consistent with the proposed mechanism for sulfate activation which involves sulfate binding to the enzyme (Anderson, W. B., Horne, R. N., and Nordlie, R. C. (1968) Biochemistry 7, 3997-4004). The second order rate constant calculated for formation of glucose 6-vanadate at pH 7.0 is 2.4 M-1 s-1. The corresponding values for glucose 6-phosphate and glucose 6-arsenate formation are approximately 9 X 10(-11) M-1 s-1 and 6.3 X 10(-6) M-1 s-1 (Lagunas, R. (1980) Arch. Biochem. Biophys. 205, 67-75).

Glucose↗
PubMed2003

Synthesis and characterization of vanadium(V)-phosphinimide complexes.

Synthetic routes to vanadium(V)-phosphinimide derivatives are addressed. Initial synthetic efforts afforded the known compound formulated as VCl(2)(NPPh(3))(3) which was crystallographically determined to be the salt [VCl(NPPh(3))(3)]Cl (1). Reactions of the vanadium-imide precursors VCl(3)(NAr) (Ar = Ph, C(6)H(3)-2,6-iPr(2)) with R(3)PNSiMe(3) (R = Ph, iPr, tBu) afforded VCl(2)(NPh)(NPPh(3)) (4), VCl(2)(NPh)(NPiPr(3)) (5), VCl(2)(NPh)(NPtBu(3)) (6), VCl(2)(NC(6)H(3)-2,6-iPr(2))(NPPh(3)) (7), VCl(2)(NC(6)H(3)-2,6-iPr(2))(NPiPr(3)) (8), and VCl(2)(NC(6)H(3)-2,6-iPr(2))(NPtBu(3)) (9) in yields ranging from 72% to 84%. Subsequent alkylation or arylation reactions resulted in VMe(2)(NC(6)H(3)-2,6-iPr(2))(NPtBu(3)) (10), VPh(2)(NPh)(NPtBu(3)) (11), VPh(2)(NC(6)H(3)-2,6-iPr(2))(NPiPr(3)) (12), and VPh(2)(NC(6)H(3)-2,6-iPr(2))(NPtBu(3)) (13) while substitution reactions with Li[N(SiMe(3))(2)] and Li[SBn] gave VCl(N(SiMe(3))(2))(NPh)(NPtBu(3)) (14) and V(SBn)(2)(NC(6)H(3)-2,6-iPr(2))(NPtBu(3)) (15) in yields ranging from 40% to 49% yield. Polarization of the N-P phosphinimide bond and V-N multiple bond character are evidenced by crystallographic data.

Journal Article↗
PubMed2001

A three-dimensional inorganic/organic hybrid vanadium oxide complex with pentacoordinate CoII, [CoV2O6(4,4'-bipy)].

The title compound, poly[[cobalt(II)-mu-(hexaoxodivanadium-O:O')]-mu-bipyridine-N:N'], [CoV2O6(C10H8N2)], has been prepared hydrothermally and characterized by elemental analyses, IR spectroscopy and single-crystal X-ray diffraction. The structure consists of bimetallic oxide layers, [Co2V4O12], linked through 4,4'-bipyridine ligands into a three-dimensional network.

Journal Article↗
PubMed1996

Hydrothermal Syntheses and Structural Characterization of Layered Vanadium Oxides Incorporating Organic Cations: alpha-, beta-(H(3)N(CH(2))(2)NH(3))[V(4)O(10)] and alpha-, beta-(H(2)N(C(2)H(4))(2)NH(2))[V(4)O(10)].

Four new layered mixed-valence vanadium oxides, which contain interlamellar organic cations, alpha-(H(3)N(CH(2))(2)NH(3))[V(4)O(10)] (1a), beta-(H(3)N(CH(2))(2)NH(3))[V(4)O(10)] (1b), alpha-(H(2)N(C(2)H(4))(2)NH(2))[V(4)O(10)] (2a), and beta-(H(2)N(C(2)H(4))(2)NH(2))[V(4)O(10)] (2b), have been prepared under hydrothermal conditions and their single-crystal structures determined: 1a, triclinic, space group P&onemacr;, a = 6.602(2) Å, b = 7.638(2) Å, c = 5.984(2) Å, alpha = 109.55(3) degrees, beta = 104.749(2) degrees, gamma = 82.31(3) degrees, Z = 1; 1b, triclinic, P&onemacr;, a = 6.387(1) Å, b = 7.456(2) Å, c = 6.244(2) Å, alpha = 99.89(2) degrees, beta = 102.91(2) degrees, gamma = 78.74(2) degrees, Z = 1; 2a, triclinic, P&onemacr;, a = 6.3958(5) Å, b = 8.182(1) Å, c = 6.3715(7) Å, alpha = 105.913(9) degrees, beta = 104.030(8) degrees, gamma = 94.495(8) degrees, Z = 1; 2b, monoclinic, space group P2(1)/n, a = 9.360(2) Å, b = 6.425(3) Å, c = 10.391(2) Å, beta = 105.83(1) degrees, Z = 2. All four of the compounds contain mixed-valence V(5+)/V(4+) vanadium oxide layers constructed from V(5+)O(4) tetrahedra and pairs of edge-sharing V(4+)O(5) square pyramids with protonated organic amines occupying the interlayer space.

Journal Article↗
PubMed2003

Vanadium-induced apoptosis and pulmonary inflammation in mice: Role of reactive oxygen species.

Pulmonary exposure to metals and metal-containing compounds is associated with pulmonary inflammation, cell death, and tissue injury. The present study uses a mouse model to investigate vanadium-induced apoptosis and lung inflammation, and the role of reactive oxygen species (ROS) in this process. Aspiration of the pentavalent form of vanadium, V (V), caused a rapid influx of polymorphonuclear leukocytes into the pulmonary airspace with a peak inflammatory response at 6 h post-exposure and resolution by 72 h. During this period, the number of apoptotic lung cells which were predominantly neutrophils increased considerably with a peak response at 24 h accompanied by no or minimum necrosis. After 24 h when the V (V)-induced inflammation was in the resolution phase, an increased influx of macrophages and engulfment of apoptotic bodies by these phagocytes was observed, supporting the role of macrophages in apoptotic cell clearance and resolution of V (V)-induced lung inflammation. Electron spin resonance (ESR) studies using lavaged alveolar macrophages showed the formation of ROS, including O(2)(*-), H(2)O(2), and (*)OH radicals which were confirmed by inhibition with free radical scavengers. The mechanism of ROS generation induced by V (V) involved the activation of an NADPH oxidase complex and the mitochondrial electron transport chain. The ROS scavenger, catalase (H(2)O(2) scavenger), effectively inhibited both lung cell apoptosis and the inflammatory response, whereas superoxide dismutase (SOD) (O(2)(*-) scavenger) and the metal chelator, deferoxamine (inhibitor of (*)OH generation by Fenton-like reactions) had lesser effects. These results indicate that multiple oxidative species are involved in V (V)-induced lung inflammation and apoptosis, and that H(2)O(2) plays a major role in this process.

Administration, Inhalation↗
PubMed2003

The first example of a seven-coordinate vanadium(III) thiolate complex containing the hydrazine molecule, an intermediate of nitrogen fixation.

The first example of a seven-coordinate vanadium(III) thiolate complex, [V(PS3' ')(N(2)H(4))(3)] (1), where PS3' ' = [P(C(6)H(3)-3-Me(3)Si-2-S)(3)](3)(-), has been synthesized and characterized. Compound 1 contains a tetradentate ligand (PS3' ') and three hydrazine molecules, forming a capped octahedral geometry. A five-coordinate vanadium(III) complex, [V(PS3)(1-Me-Im)] (2), where PS3 = [P(C(6)H(4)-2-S)(3)](3)(-) and 1-Me-Im = 1-methyl-imidazole, was also obtained. Compound 2 adopts a trigonal bipyramidal geometry, in which the vanadium is ligated by the title ligand, PS3, and one 1-Me-Im molecule.

Journal Article↗
PubMed2003

New vanadium phosphate ([(phen)VIVO]2(VV2O5)(HPO4))n with chiral layer architecture.

A new layered vanadium phosphate ([(phen)V(IV)O](2)(V(V)(2)O(5))(HPO(4))n has been hydrothermally synthesized and structurally characterized by elemental analysis, IR, and single-crystal X-ray diffraction. This compound crystallized in the monoclinic space group P2/c with a = 9.979(2) A, b = 9.886(2) A, c = 15.298(3) A, beta = 102.86(3) degrees, V = 1471.3(5) A(3), and Z = 4. In the structure of this compound, two nitrogen atoms of 1,10-phen are directly coordinated to the vanadium skeleton. Interestingly, the crystal structure consists of two types of chiral layers, one left-handed and the other right-handed, which lead to a racemic solid-state compound. In each layer, there coexist three distinct rings, described as a 8-membered ring [V(2)(oct)P(2)O(4)], 12-membered ring [V(2)(omicron)(ct)V(2)(tet)P(2)O(6)], and 16-membered ring [V(2)(omicron)(ct)V(4)(tet)P(2)O(8)].

Journal Article↗
PubMed2005

Polyoxometalates: introduction to a class of inorganic compounds and their biomedical applications.

An increasing number of potential applications for polyoxometalates in human medicine have been reported in the literature. These inorganic complexes are composed of early transition metals (mainly molybdenum, tungsten and vanadium) and oxygen. The present review gives an introduction into the chemistry of these compounds, and an overview of the principal studies of their biological and biochemical effects and their therapeutic potential. The reported antitumoral and antibiotic properties of molybdates and tungstates in vitro and in vivo are compiled and discussed, as are their influences on the blood glucose level in diabetic animals. Aspects of antiviral activities and cell penetration are treated.

Animals↗
PubMed2002

Synthesis, characterization and antiamoebic activity of benzimidazole derivatives and their vanadium and molybdenum complexes.

Reaction of [MoO(2)(acac)(2)] (where, acac=acetyl acetone) and KVO(3) with 2-(salicylidieneimine) benzimidazole lead to form new complexes [MoO(2)(sal-BMZ)(2)] and K [VO(2)(sal-BMZ)(2)] [where, sal-BMZ=2-(salicylidieneimine) benzimidazole], which showed the monobasic bidentate nature of the ligand in which the phenolic oxygen and the imine nitrogen of the ligand are coordinated to the metal ion. These complexes were characterized along with nine other complexes of oxoperoxovanadium (V), molybdenum (Vl) and tungsten (Vl) with benzimidazole derivatives and screened in vitro by micro dilution technique for their amoebicidal activity with a view to search for a more effective agent against Entamoeba histolytica suggests that compound 2 and 3 might be endowed with important antiamoebic properties since they showed IC(50 )values in a microM range.

Amebicides↗
PubMed2006

Antitumor activity of polyoxomolybdate, [NH3Pri]6[Mo7O24].3H2O, against, human gastric cancer model.

Polyoxometalates are negatively charged inorganic compounds which contain metal ions such as tungsten, molybdenum, vanadium etc. and which make clusters with the surrounding oxygen atoms. [NH3Pri]6[Mo7O24].3H2O (PM-8) was found to be a significant antitumor polyoxomolybdates. It had already been reported that the PM-8 suppressed the growth of Co-4 human colon cancer, MX-1 human breast cancer and OAT human lung cancer xenografted in nude mice. However, the mechanism of the antitumor activity has not been clarified. In this study, the antitumor activity of one of the metal oxide clusters (polyoxometalates), hexabis(isopropylammonium) heptamolybdate trihydrate, [NH3Pri]6[Mo7O24].3H2O (PM-8) were shown in an MTS assay. DNA ladder formation and detection of apoptotic bodies in nuclei were revealed that antitumor activity of PM-8 in MKN45 cells was due to apoptosis. It is concluded that the observation of significant tumor growth suppression of PM-8 in MKN45-bearing mice results from the induction of apoptosis. PM-8 shows promise as a novel anti-cancer agent.

Animals↗